XML 69 R46.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Fair Value Measurements - Schedule of Observable Inputs in Valuation of Deferred Consideration (Details)
$ in Millions
Jun. 30, 2024
USD ($)
$ / shares
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Deferred consideration | $ $ 12.4
Level 2 | Share Price  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Insmed share price (in usd per share) | $ / shares 67.00